Ziopharm slides on news of patient deaths

Ziopharm Oncology Inc. (NASDAQ:ZIOP) lost $0.66 (12%) to $5.01 on Friday after it reported three patient deaths in a Phase I

Read the full 216 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE